GENE ONLINE|News &
Opinion
Blog

ESG
GHG Emissions as a ESG Metric
2023-06-07
Brazil’s Evolving ESG Landscape from the Amazon to Atlantic Forest
2023-05-31
A Close Look at the Evolution of ESG in Biopharma
2023-05-22
Everything You Need to Know About Vertical Solar Systems
2023-05-15
How Can We Move Away From the Extraction-Based Economy?
2023-05-08
ESG’s Growing Impact on Human Rights
2023-05-02
Is ESG the Solution to Accelerate Agricultural Returns?
2023-04-24
Governmental Action for a Better Future
2023-04-17
Why ESG Is a Smart Choice for Investors and Businesses
2023-04-10
On-Grid or Off-Grid Solar System: Which One is the Best for You?
2023-04-03
Dual Function Materials’ Value for a Greener Future
2023-03-29
Ways to Reduce Carbon Emission in Cement Manufacturing
2023-03-26
Comparing ESG Regulations in the U.S., the U.K., and the EU
2023-03-21
The World of ESG: Standards and their Organizations
2023-03-14
LATEST
Revolutionizing Treatment: ASGCT’s Clinical Trials Spotlight on Immunotherapy, Cancer Vaccines, and Auditory Diseases
2024-05-09
Advancing Health: ASGCT’s Clinical Trials Spotlight on Cell Therapy and Cell-Based Gene Therapy
2024-05-09
Infinitopes’ Article in Peer-Reviewed Journal Seeks to Unlock the Potential of Cancer Vaccines
2024-05-09
Profluent Achieves Human Genome Editing Milestone Using OpenCRISPR-1: The First AI-Generated, Open-Source Gene Editor
2024-05-08
The Gene & Cell Therapy Landscape: Recent Approvals and Upcoming Therapeutics of Interest
2024-05-06
Exploring Key Areas of RNA Therapeutics Development: Your Blueprint for Maximizing ASGCT Content
2024-05-06
Mastering Gene & Cell Therapy: Your Blueprint for Maximizing ASGCT Content
2024-05-06
EVENT
Scroll to Top